Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07298096
What this trial is testing

A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)

Who this might be right for
Cancer
M.D. Anderson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05003037
What this trial is testing

Surufatinib Combined With Toripalimab and Chemotherapy in the Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Li Zhang, MD 106
Testing effectiveness (Phase 2)Ended earlyNCT04210037
What this trial is testing

Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Ascentage Pharma Group Inc. 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04504071
What this trial is testing

Dacomitinib in Lung Cancer With Uncommon EGFR Mutations

Who this might be right for
Non-small Cell Lung Cancer MetastaticEGF-R Positive Non-Small Cell Lung Cancer
Shanghai Chest Hospital 30
Large-scale testing (Phase 3)Study completedNCT00085826
What this trial is testing

A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients

Who this might be right for
Non-Small Cell Lung Cancer
Astellas Pharma Inc 600
Testing effectiveness (Phase 2)UnknownNCT04659785
What this trial is testing

Fluzoparib Combined With Apatinib as Second-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer（FA-ES-SCLC）

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Tianjin Medical University Second Hospital 53
Testing effectiveness (Phase 2)Looking for participantsNCT06047379
What this trial is testing

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Who this might be right for
Diffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more
Neonc Technologies, Inc. 134
Large-scale testing (Phase 3)Active Not RecruitingNCT06082635
What this trial is testing

TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Shenzhen TargetRx Co., Ltd. 321
Not applicableUnknownNCT03108560
What this trial is testing

Sublobar Resection Versus Lobectomy for cT1N0M0 Non-small-cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Shanghai Zhongshan Hospital 600
Not applicableStudy completedNCT04663685
What this trial is testing

MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.

Who this might be right for
ArthritisCancerCardiovascular Diseases+9 more
University of Waterloo 30
Testing effectiveness (Phase 2)Looking for participantsNCT05948813
What this trial is testing

TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases

Who this might be right for
NSCLCEGFR Activating MutationBrain Metastases
TYK Medicines, Inc 420
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07841106
What this trial is testing

Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain Metastases.

Who this might be right for
Lung Cancer (Non-Small Cell)RadiationBrain Injury+2 more
Jiangmen Central Hospital 49
Large-scale testing (Phase 3)Active Not RecruitingNCT03703297
What this trial is testing

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Who this might be right for
Small Cell Lung Cancer
AstraZeneca 730
Testing effectiveness (Phase 2)UnknownNCT01872403
What this trial is testing

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the Lung

Who this might be right for
Non-small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University 120
Testing effectiveness (Phase 2)WithdrawnNCT03868423
What this trial is testing

Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers

Who this might be right for
Advanced Malignant NeoplasmALK Fusion Protein ExpressionALK Gene Amplification+8 more
Sameek Roychowdhury
Not applicableNot Yet RecruitingNCT07590596
What this trial is testing

Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer

Who this might be right for
Pulmonary NoduleSuspected Lung CancerPreoperative Decision-Making
Sichuan Cancer Hospital and Research Institute 200
Not applicableEnrolling By InvitationNCT07122882
What this trial is testing

Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance

Who this might be right for
Oncogene-addicted Non Small Cell Lung CancerEGFR MutationALK Fusion-positive Solid or CNS Tumors+10 more
Chang Gung Memorial Hospital 40
Not applicableLooking for participantsNCT04937283
What this trial is testing

Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm

Who this might be right for
Lung Adenocarcinoma
Shanghai Pulmonary Hospital, Shanghai, China 690
Not applicableStudy completedNCT01802203
What this trial is testing

TrūFreeze® Spray Cryotherapy Patient Registry

Who this might be right for
Barrett EsophagusEsophageal DysplasiaEsophageal Neoplasm+3 more
US Endoscopy Group Inc. 275
Next Page